Suppr超能文献

鉴定脓毒症 T 细胞和全血细胞中 miRNA 定量的合适对照。

Identification of suitable controls for miRNA quantification in T-cells and whole blood cells in sepsis.

机构信息

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.

Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany.

出版信息

Sci Rep. 2019 Oct 31;9(1):15735. doi: 10.1038/s41598-019-51782-w.

Abstract

Complex immune dysregulation is a hallmark of sepsis. The occurring phases of immunosuppression and hyperinflammation require rapid detection and close monitoring. Reliable tools to monitor patient's immune status are yet missing. Currently, microRNAs are being discussed as promising new biomarkers in sepsis. However, no suitable internal control for normalization of miRNA expression by qPCR has been validated so far, thus hampering their potential benefit. We here present the first evaluation of endogenous controls for miRNA analysis in human sepsis. Novel candidate reference miRNAs were identified via miRNA microArray. TaqMan qPCR assays were performed to evaluate these microRNAs in T-cells and whole blood cells of sepsis patients and healthy controls in two independent cohorts. In T-cells, U48 and miR-320 proved suitable as endogenous controls, while in whole blood cells, U44 and miR-942 provided best stability values for normalization of miRNA quantification. Commonly used snRNA U6 exhibited worst stability in all sample groups. The identified internal controls have been prospectively validated in independent cohorts. The critical importance of housekeeping gene selection is emphasized by exemplary quantification of imuno-miR-150 in sepsis patients. Use of appropriate internal controls could facilitate research on miRNA-based biomarker-use and might even improve treatment strategies in the future.

摘要

复杂的免疫失调是脓毒症的一个标志。免疫抑制和过度炎症的发生阶段需要快速检测和密切监测。目前,还没有可靠的工具来监测患者的免疫状态。目前,microRNAs 被认为是脓毒症有前途的新生物标志物。然而,到目前为止,还没有经过验证的 qPCR 用于 microRNA 表达标准化的合适内参,从而阻碍了它们的潜在益处。我们在这里首次评估了 microRNA 分析在人类脓毒症中的内参。通过 microRNA 微阵列鉴定了新的候选内参 microRNAs。在两个独立的队列中,通过 TaqMan qPCR 检测在脓毒症患者和健康对照的 T 细胞和全血细胞中评估这些 microRNAs。在 T 细胞中,U48 和 miR-320 被证明适合作为内参,而在全血细胞中,U44 和 miR-942 为 microRNA 定量的标准化提供了最佳的稳定性值。常用的 snRNA U6 在所有样本组中稳定性最差。所鉴定的内参已在独立队列中进行了前瞻性验证。通过对脓毒症患者免疫 microRNA-150 的定量示例,强调了管家基因选择的重要性。使用适当的内参可以促进基于 microRNA 的生物标志物的研究,并可能在未来甚至改善治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78b/6823537/37717956cb57/41598_2019_51782_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验